Biotechnology

Unlike the NNVC plunge with seemed to have no reason to occur, GNBT had “bad news” on October 20th when it released a Going Concern notice as required by Nasdaq regulations. Before we discuss the going concern issue, I would like to visit the reasons I traded GNBT earlier in the year. Generix has several [...]